ziprasidone

释义

[医]齐拉西酮；

双语例句

用作名词(n.)

After its approal by the US Food and Drug Administration, the second-generation antipsychotic, ziprasidone hydrochloride, was also included.
而且，自从第二代抗精神病药盐酸齐拉西酮获得美国食品药品监督局批准后，该药也被包括在内。

权威例句

1. Methods: select 30 cases of female patients with schizophrenia, give ziprasidone treatment, treatment 8 weeks.

方法：选择30例女性精神分裂症患者，给予齐拉西酮治疗，疗程8周。

2. And the incidence rate of extrapyramidal symptoms was lower in ziprasidone group than in haloperidol group (P0.05).

氟哌啶醇组锥体外系的发生率明显高于齐拉西酮组，差异有统计学意义（P0.05）。

3. Objective To observe the efficacy and side effects of ziprasidone combined amitriptyline in the treatment of treatment-refractory depression.

目的观察齐拉西酮合并阿米替林治疗难治性抑郁症的疗效和毒副作用。

211.151.93.212

4. Results: ziprasidone efficient, without obvious for 86.7% weight, orthostatic hypotension, dizziness, sleepiness and so on adverse reactions.

结果：齐拉西酮有效率为86.7％，无明显增加体重，有直立性低血压、头晕、嗜睡等不良反应。

5. After its approval by the US Food and Drug Administration, the second-generation antipsychotic, ziprasidone hydrochloride, was also included.

而且，自从第二代抗精神病药盐酸齐拉西酮获得美国食品药品监督局批准后，该药也被包括在内。

6. AIM: To evaluate the efficacy and reliability of Ziprasidone injection made in China in treating acute onset of schizophrenia.

目的：评价国产甲磺酸齐拉西酮注射液治疗精神分裂症急性激越症状的疗效和安全性。

7. OBJECTIVE:To study the pharmacokinetics of a single dose of intramuscularly injected ziprasidone mesylate in healthy volunteers.

目的：研究单剂量肌肉注射甲磺酸齐拉西酮后药动学。

8. Methods 72 cases of elderly patients with schizophrenia were randomly divided into ziprasidone group and per- phenazine group for 8 weeks.

方法将72例老年精神分裂症患者随机分为2组，分别给予齐拉西酮和奋乃静治疗8周。

9. Objective To explore the clinical influence of ziprasidone used for therapy of older patients with schizophrenia long term on rate of thrombus disease.

目的探讨齐拉西酮长期应用于老年精神分裂症患者对其血栓病变发病率的影响。

10. ObjectiveTo evaluate the clinical curative effect and security of Ziprasidone and Risperidone in the treatment of schizophrenia.

目的：通过与利培酮的对比，评价齐拉西酮治疗精神分裂症的临床疗效及安全性。

11. Quetiapine and olanzapine were proposed for both schizophrenia and bipolar mania, while the application for ziprasidone was limited to bipolar mania.

我们提议奎硫平和奥氮平用于精神分裂和双相躁狂，同时，对齐拉西酮的应用限制在双相躁狂上。

12. Conclusion For the aim of enhancing clinical safety, fat and CCVD patients can choose ziprasidone for therapy.

结论对于肥胖以及有心脑血管疾病的老年患者，可以考虑使用齐拉西酮，以提高临床安全性。

13. ConclusionAt the end of 8 weeks, the effects of the two groups are familiar, the side effects of Ziprasidone is fewer than Risperidone.

结论：到第8周末，两组疗效相当，不良反应齐拉西酮组明显少于利培酮组。

14. Conclusion:Ziprasidone has good safety, action fast and few adverse reactions, can be used as the first choice of teatment for senile schizophrenia.

结论：齐拉西酮具有起效快、安全性好、不良反应少的特点，可作为老年精神分裂症的首选药物。

15. Objective To compare the efficacy and the safety of Ziprasidone with Aripiprazole in treating schizophrenia with predominantly negative symptoms.

目的比较齐拉西酮与阿立哌唑治疗以阴性症状为主的精神分裂症的疗效和安全性。

16. Objective To compare the curative effect and safety of ziprasidone and quetiapine combined with perphenazine in treating schizophrenia.

目的比较齐拉西酮和奎硫平与奋乃静合并用药对精神分裂症的治疗效果和安全性。

17. Conclusion Ziprasidone is a better drugs for the treatment of schizophrenia for its good efficacy and safety.

结论齐拉西酮是一种较理想的治疗精神分裂症的药物，其疗效确切，安全性较好，值得临床推广应用。

18. Objective To compare the efficacy and side effects of Ziprasidone and Aripiprazole in the treatment of schizophrenia with predominantly negative symptoms.

目的对比齐拉西酮和阿立呱唑治疗阴性症状为主的精神分裂症的疗效与不良反应。

19. Objective To compare the effects of ziprasidone and chlorpromazine on cognitive function in the first-onset schizophrenic patients.

目的比较齐拉西酮与氯丙嗪对首发精神分裂症病人认知功能的影响。

20. Objective To compare the effect of ziprasidone and risperidone on the efficacy and cognitive function in first-episode schizophrenia.

目的探讨齐拉西酮与利培酮对首发分裂症的疗效和安全性，以及对认知功能影响。

21. Conclusions Ziprasidone and quetiapine combined with perphenazine are effective in treating schizophrenia and even safer treatment can be gained by quetiapine combined with perphenazine.

结论齐拉西酮与奋乃静合用与奎硫平、奋乃静合用治疗精神分裂症均有较好疗效，且安全性能以奎硫平合用奋乃静高。

22. Objective To study the curative effect and side-effect of ziprasidone and quetiapine in treating patients with senile psychosis.

目的探讨齐拉西酮与奎硫平对老年性精神分裂症的疗效和不良反应。

23. Conclusion Ziprasidone in treatment of elderly schizophrenia is of good efficacy and relatively small adverse reactions.

结论齐拉西酮治疗老年精神分裂症患者疗效好，不良反应相对较小。

24. Results The overall efficacy rate of ziprasidone(64.29%) was higher than that of risperidone (42.85%).

结果齐拉西酮组总有效率为64.29%，明显高于利培酮组的42.85%。

25. Abstr: Objective To explore the efficacy and safety of ziprasidone and risperidone in the treatment of schizophrenia in children and adolescents.

文章摘要：目的探讨齐拉西酮与利培酮治疗首发儿童青少年精神分裂症患者的疗效和安全性。

26. Conclusion Ziprasidone has clear efficacy in the treatment of schizophrenia with predominantly negative symptoms, and has light side effects.

结论齐拉西酮治疗以阴性症状为主的精神分裂症疗效确切，不良反应轻微。

27. Conclusion ziprasidone may significant improve in cognitive function in first-onset schizophrenia patients.

结论齐拉西酮对首发精神分裂症病人认知功能的改善明显。

28. Of the 41 patients (73 percent) who responded to ziprasidone or chlorpromazine, 30 were able to maintain this response on ziprasidone.

对41例（73 ％ ）的，他当时的反应齐拉西酮或氯丙嗪，有30人能在这方面的反应就齐拉西酮。

29. Of the 41 patients (73 percent) who responded to ziprasidone or chlorpromazine, 30 were able to maintain this response on ziprasidone.

对41例（73 ％ ）的，他当时的反应齐拉西酮或氯丙嗪，有30人能在这方面的反应就齐拉西酮。

30. Xiangtan Kaiyuan Chemicals Co., Ltd. is a specialized manufacturer of pharmaceutical intermediates. Its products include the intermediates for Lamivudine, Ziprasidone and Olanzapine.

湘潭市开元化学有限公司是一家专业生产医药中间体的厂家。其产品包括拉米呋啶、拉西酮及奥氮平的中间体。

-- 来源 --